Want to see ZYBT full AI Analyst Report?
Total Valuation
Zhengye Biotechnology Holding Ltd. has a market cap or net worth of $22.95M. The enterprise value is $272.93M.
Market Cap$22.95M
Enterprise Value$272.93M
Share Statistics
Zhengye Biotechnology Holding Ltd. has 10,965,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,965,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhengye Biotechnology Holding Ltd.’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -17.87%.
Return on Equity (ROE)-0.28
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-17.87%
Return on Capital Employed (ROCE)-0.22
Revenue Per Employee418.57K
Profits Per Employee-298.45K
Employee Count278
Asset Turnover0.27
Inventory Turnover2.36
Valuation Ratios
The current PE Ratio of Zhengye Biotechnology Holding Ltd. is ―. Zhengye Biotechnology Holding Ltd.’s PEG ratio is 0.00841.
PE Ratio―
PS Ratio3.27
PB Ratio1.52
Price to Fair Value1.52
Price to FCF541.63
Price to Operating Cash Flow6.22
PEG Ratio0.00841
Income Statement
In the last 12 months, Zhengye Biotechnology Holding Ltd. had revenue of 116.36M and earned -69.78M in profits. Earnings per share was -1.40.
Revenue116.36M
Gross Profit23.87M
Operating Income-68.25M
Pretax Income-71.87M
Net Income-69.78M
EBITDA-42.52M
Earnings Per Share (EPS)-1.40
Cash Flow
In the last 12 months, operating cash flow was 40.20M and capital expenditures -1.12M, giving a free cash flow of 39.08M billion.
Operating Cash Flow40.20M
Free Cash Flow39.08M
Free Cash Flow per Share3.56
Dividends & Yields
Zhengye Biotechnology Holding Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.39
52-Week Price Change-86.71%
50-Day Moving Average6.15
200-Day Moving Average―
Relative Strength Index (RSI)35.40
Average Volume (3m)871.70K
Important Dates
Zhengye Biotechnology Holding Ltd. upcoming earnings date is Apr 28, 2026, Before Open (Confirmed).
Last Earnings DateJul 3, 2025
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Zhengye Biotechnology Holding Ltd. as a current ratio of 1.14, with Debt / Equity ratio of 30.05%
Current Ratio1.14
Quick Ratio0.82
Debt to Market Cap0.20
Net Debt to EBITDA-0.58
Interest Coverage Ratio-20.07
Taxes
In the past 12 months, Zhengye Biotechnology Holding Ltd. has paid 11.10M in taxes.
Income Tax11.10M
Effective Tax Rate-0.15
Enterprise Valuation
Zhengye Biotechnology Holding Ltd. EV to EBITDA ratio is -9.54, with an EV/FCF ratio of 576.83.
EV to Sales3.48
EV to EBITDA-9.54
EV to Free Cash Flow576.83
EV to Operating Cash Flow30.41
Balance Sheet
Zhengye Biotechnology Holding Ltd. has $51.89M in cash and marketable securities with $75.08M in debt, giving a net cash position of -$23.19M billion.
Cash & Marketable Securities$51.89M
Total Debt$75.08M
Net Cash-$23.19M
Net Cash Per Share-$2.12
Tangible Book Value Per Share$5.32
Margins
Gross margin is 8.30%, with operating margin of -58.66%, and net profit margin of -59.97%.
Gross Margin8.30%
Operating Margin-58.66%
Pretax Margin-61.77%
Net Profit Margin-59.97%
EBITDA Margin-36.54%
EBIT Margin-58.84%
Analyst Forecast
The average price target for Zhengye Biotechnology Holding Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-37.53%
EPS Growth Forecast-717.42%